Vaccine Adjuvants Market 2020-2024 | Increase Awareness About Immunization Programs and Access to Vaccines to Boost Growth | Technavio

Technavio has been monitoring the vaccine adjuvants market and it is poised to grow by USD 401.94 bn during 2020-2024, progressing at a CAGR of almost 11% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Request a free sample report

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200320005409/en/

The market is concentrated, and the degree of concentration will accelerate during the forecast period. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Increase awareness about immunization programs and access to vaccines has been instrumental in driving the growth of the market.

Vaccine Adjuvants Market 2020-2024: Segmentation

Vaccine Adjuvants Market is segmented as below:

Application

• Infectious Diseases
• Cancer
• Other Diseases

Geographic Segmentation

• Asia
• Europe
• North America
• ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40163

Vaccine Adjuvants Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our vaccine adjuvants market report covers the following areas:

• Vaccine Adjuvants Market size
• Vaccine Adjuvants Market trends
• Vaccine Adjuvants Market industry analysis

This study identifies development of nanoparticle adjuvants as one of the prime reasons driving the vaccine adjuvants market growth during the next few years.

Vaccine Adjuvants Market 2020-2024: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the vaccine adjuvants market , including some of the vendors such as Agenus Inc., Avanti Polar Lipids Inc., Croda International Plc, CSL Ltd. and GlaxoSmithKline Plc. Backed with competitive intelligence and benchmarking, our research reports on the vaccine adjuvants market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Vaccine Adjuvants Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist vaccine adjuvants market growth during the next five years
• Estimation of the vaccine adjuvants market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the vaccine adjuvants market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of vaccine adjuvants market vendors

Table of Content

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Parent market
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

• Market segmentation by application
• Comparison by application
• Infectious diseases - Market size and forecast 2019-2024
• Cancer - Market size and forecast 2019-2024
• Other diseases - Market size and forecast 2019-2024
• Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 11: MARKET TRENDS

• Increase in R&D of novel vaccine adjuvants
• Development of nanoparticle adjuvants
• Rising number of collaborations

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agenus Inc.
• Avanti Polar Lipids Inc.
• Croda International Plc
• CSL Ltd.
• GlaxoSmithKline Plc
• InvivoGen
• Merck KGaA
• OZ Biosciences SAS
• SEPPIC SA
• Vaxine Pty Ltd.

PART 14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200320005409/en/